DUBLIN (AP) _ Avadel Pharmaceuticals PLC (AVDL) on Monday reported a third-quarter loss of $15.8 million, after reporting a profit in the same period a year earlier.
The Dublin-based company said it had a loss of 43 cents per share.
The specialty pharmaceutical company posted revenue of $19.8 million in the period.
Avadel expects full-year revenue in the range of $90 million to $105 million.
The company's shares closed at $4.02. A year ago, they were trading at $9.91.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AVDL at https://www.zacks.com/ap/AVDL